Microcompetition and the origin of cancer

European Journal of Cancer

Volumn 41, Issue 1, 2005, Pages 15-19

  Jariwalla, Raxit J ^a  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Cancer; Cellular allocation; Foreign N boxes; Limiting transcription factor; Microcompetition

Indexed keywords

BRCA1 PROTEIN; TRANSCRIPTION FACTOR; VIRUS DNA;

CANCER CELL; CARCINOGENESIS; CYTOMEGALOVIRUS; DNA MODIFICATION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HUMAN; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REVIEW; WILD TYPE;

EID: 11144265328     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.09.027     Document Type: Article

References (23)

1. H. Polansky Microcompetition with foreign DNA and the origin of chronic disease 2003 Center for the Biology of Chronic Disease Rochester, NY
2. R.C. Boland, and L. Ricciardcello How many mutations does it take to make a tumor? Proc Natl Acad Sci USA 96 1999 14675 14677
3. C. Lengauer, K.W. Kinzler, and B. Vogelstein Genetic instabilities in human cancer Nature 396 6712 1998 643 649
4. I. Tomlinson, and W. Bodmer Selection. The mutation rate and cancer: ensuring that the tail does not wag the dog Natl Med 5 1999 11 12
5. I. Tomlinson, P. Sasiemi, and W. Bodmer How many mutations in a cancer? Am J Pathol 160 2002 755 758
6. F. Magdinier, S. Ribieras, and G.M. Lenoir Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region Oncogene 17 24 1998 3169 3176
7. P.G. Rio, J.C. Maurizis, and M. Peffault de Latour Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene Int J Cancer 80 6 1999 823 826
8. P.A. Russell, P.D. Pharoah, and K. De Foy Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers Int J Cancer 87 3 2000 317 321
9. M.M. Keane, S.A. Ettenberg, and G.A. Lowrey Fas expression and function in normal and malignant breast cell lines Cancer Res 56 20 1996 4791 4798
10. L.M. Butler, P.J. Hewett, and W.J. Butler Down-regulation of Fas gene expression in colon cancer is not a result of allelic loss or gene rearrangement Br J Cancer 77 9 1998 1454 1459
11. H. Das, T. Koizumi, and T. Sugimoto Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR Br J Cancer 82 10 2000 1682 1688
12. E. Atlas, M. Stramwasser, and K. Whiskin GA-binding protein α/β is a critical regulator of the BRCA1 promoter Oncogene 19 15 2000 1933 1940
13. X.R. Li, A.S. Chong, and J. Wu Transcriptional regulation of Fas gene expression by GA-binding protein and AP-1 in T-cell antigen receptor. CD3 complex-stimulated T-cells J Biol Chem 274 49 1999 35203 35210
14. Y. Sowa, Y. Shiio, and T. Fujita Retinoblastoma binding factor 1 site in the core promoter region of the human RB gene is activated by hGABP/E4TF1 Cancer Res 57 15 1997 3145 3148
15. V. Cherington, M. Brown, and E. Paucha Separation of simian virus 40 large-T-antigen-transforming and origin-binding functions from the ability to block differentiation Mol Cell Biol 8 3 1988 1380 1384
16. C. Higgins, S. Chatterjee, and V. Cherington The block of adipocyte differentiation by a C-terminally truncated, but not by full-length, simian virus 40 large tumor antigen is dependent on an intact retinoblastoma susceptibility protein family binding domain J Virol 70 2 1996 745 752
17. S. Awazu, K. Nakata, and D. Hida Stable transfection of retinoblastoma gene promotes contact inhibition of cell growth and hepatocyte nuclear factor-1-mediated transcription in human hepatoma cells Biochem Biophys Res Commun 252 1 1998 269 273
18. S.J. Choi, Y. Oba, and Y. Gazitt Antisense inhibition of macrophage inflammatory protein 1-α blocks bone destruction in a model of myeloma bone disease J Clin Invest 108 12 2001 1833 1841
19. R.J. Jariwalla, L. Aurelian, and P.O.P. Ts'o Immortalization and neoplastic transformation of normal diploid cells by defined cloned DNA fragments of herpes simplex virus type 2 Proc Natl Acad Sci USA 80 1983 5902 5906
20. D.A. Galloway, and J.K. McDougall Transformation of rodent cells by a cloned DNA fragment of herpes simplex virus type 2 J Virol 38 1981 749 760
21. D.A. Galloway, F.M. Buonagure, and C.R. Brandt Small fragments of herpesvirus DNA with transforming activity contain insertion-like structures Proc Natl Acad Sci USA 81 1984 4736 4740
22. C. Jones, J. Ortiz, and R.J. Jariwalla Localization and comparative nucleotide sequence analysis of the transforming domain in herpes simplex DNA containing repetitive genetic elements Proc Natl Acad Sci USA 83 1986 7855 7859
23. M.A. Ali, D. McWeeney, and A. Milosavljevic Enhanced malignant transformation induced by expression of a distinct protein domain of ribonucleotide reductase large subunit from herpes simplex virus type 2 Proc Natl Acad Sci USA 88 18 1991 8257 8261